Aging populations will drive growth in the diagnosed prevalent Parkinson’s disease patient population over the forecast period, 2015–35..
By Charlotte Huntley, Epidemiologist
29 September 2016
I am an Epidemiologist at Datamonitor Healthcare. I have a Masters in Public Health from Walden University, and I’m co...
Read full bio
Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the elderly associated with considerable burden. PD is characterized by movement abnormalities and other non-motor symptoms such as dementia, depression, visual hallucinations, and autonomic dysfunction. Although PD is not fatal, there is currently no cure, and the disease’s chronicity is associated with significant morbidity and disability.
Datamonitor Healthcare estimates that in 2015, there were 1.9 million diagnosed prevalent cases of PD in the US, Japan, and five major EU markets among those aged 50 years and older. By 2035, this is forecasted to increase to approximately 2.8 million diagnosed prevalent cases, representing a growth of 46.7%. As Datamonitor Healthcare chose to apply constant prevalence proportions across the forecast period, changes in the prevalent population can be wholly attributed to demographic changes in the included markets.
Source: Datamonitor Healthcare
Datamonitor Healthcare’s Epidemiology: Parkinson’s disease module provides a detailed epidemiological analysis of the diagnosed prevalence of Parkinson’s disease across the US, Japan, and five major EU markets. This includes a 20-year diagnosed prevalence forecast (2015–35) for Parkinson’s disease segmented by age, gender, Hoehn and Yahr stage, and co-morbidities. Additionally, an interactive epidemiology datapack that incorporates treatment data from Datamonitor Healthcare’s proprietary Parkinson’s disease research survey is available.
Get your free demo of Datamonitor Healthcare tody. Simply fill out the form to the right >>>